Distribution of ABO blood groups and association to low risk of COVID-19 infection in patients

Minfei Peng, Shigao Huang, Shitu Zhu, Chaochao Chen, Jiajia Qin, Minmin He, Jie Yang, Qi ZhaoResearch 2020 · DOI

Abstract

Since the emergence of the novel coronavirus (COVID-19) in late 2019, identifying susceptible populations has been a global priority. This study investigated the correlation between ABO blood groups and COVID-19 infection risk. Analyzing 138 COVID-19 patients and 82 non-COVID-19 controls, we found that individuals with blood type O had a significantly lower risk of severe infection ($\chi^2 = 4.066, p = 0.044, OR = 0.380$). Notably, females with type O blood demonstrated a particularly low risk of progressing to severe disease. These findings suggest that ABO blood group antigens may serve as a biomarker for COVID-19 susceptibility and severity.

Introduction

The COVID-19 pandemic has presented a wide spectrum of clinical outcomes, ranging from asymptomatic infection to fatal respiratory failure. While age and comorbidities such as hypertension and diabetes were early identified as risk factors, the role of host genetics—specifically the ABO blood group system—remained less clear. As the most extensively studied erythrocyte antigen system, ABO blood groups have previously been linked to susceptibility to various infectious diseases. This study aimed to describe the distribution of ABO blood groups among patients and evaluate their association with COVID-19 infection risk and severity.

Methods

A retrospective cohort study was conducted at Taizhou Hospital in Zhejiang Province, China, involving 220 patients admitted between January 21 and February 20, 2020. Patients were categorized into three groups:

  1. Severe COVID-19 (n=32): Confirmed cases meeting severity criteria (e.g., respiratory distress, low oxygen saturation).
  2. Non-severe COVID-19 (n=106): Confirmed cases with milder symptoms.
  3. Non-COVID-19 (n=82): Patients presenting with similar symptoms but testing negative via RT-PCR.

Blood groups were determined using automated analyzers, and clinical data were extracted from electronic medical records. Statistical analyses included Chi-square tests for categorical data and Mann-Whitney U tests for continuous variables. Odds Ratios (OR) were calculated to assess relative risk.

Results

Blood Group Distribution and Severity

The distribution of blood types varied significantly across the patient groups. Type O blood appeared to offer a protective effect against severe infection. In the severe COVID-19 group, only 18.8% of patients had type O blood, compared to 37.8% in the non-COVID-19 control group.

Distribution of ABO blood groups among COVID-19 and non-COVID-19 patient groups.

Statistical analysis confirmed this trend. As shown in the table below, the comparison between severe and non-severe cases (column a4) yielded a significant p-value of 0.044 and an OR of 0.380, indicating that type O individuals were approximately 62% less likely to develop severe symptoms than those with other blood types.

Statistical analysis of ABO blood group associations with COVID-19 severity.

Gender-Specific Findings

A striking observation was the gender-specific resilience of type O individuals. Within the severe patient cohort, there were zero female patients with type O blood (0.0%), whereas 31.6% of severe male patients were type O. This suggests that the protective effect of type O might be modulated by gender-related factors.

Laboratory and Biochemical Markers

The study also identified biochemical differences between type O and non-type O COVID-19 patients. Type O patients exhibited lower levels of Alanine Aminotransferase (ALT) and Lactate Dehydrogenase (LDH), markers typically associated with liver injury and systemic tissue damage. Furthermore, type O patients had a lower Total CD19+ B cell ratio, suggesting potential differences in the initial humoral immune response to the virus.

Discussion

The findings suggest that the ABO blood group system is a significant factor in COVID-19 susceptibility. The protective effect of type O blood could be due to several mechanisms, such as anti-A and anti-B antibodies interfering with virus-cell adhesion or the antigens themselves influencing the inflammatory response.

However, this study has limitations. The sample size (n=220) is relatively small, and the data is geographically restricted to a single hospital in China. Given that blood group distributions vary globally, these results require validation in larger, multi-ethnic cohorts. Additionally, the exact molecular mechanism by which blood group antigens interact with SARS-CoV-2 remains to be fully elucidated.

Conclusion

Patients with blood type O, particularly females, appear to have a lower risk of severe COVID-19 infection. These results highlight the potential of ABO blood grouping as a simple, cost-effective tool for risk stratification. Clinicians should maintain higher vigilance for non-type O patients to mitigate the risk of clinical deterioration.

Summary updated

Abstract

Abstract Background Since December 2019, the novel coronavirus pandemic (COVID-19) has become a global health emergency. To date, studies on the correlation between ABO blood groups and COVID-19 infected risk had rarely reported. This study aimed to describe the ABO blood groups distribution and association to low risk of COVID-19 infection for effectively concerning about the susceptible population. Methods We included 138 COVID-19 diagnosed patients and 82 non- COVID-19 patients between January 21 and February 20, 2020.We compared ABO blood group distribution, gender distribution and correlation analysis in Severe, Non-severe and Non-COVID19 patients, and analyzed the laboratory indexes of type O and non-type O groups in COVID19 patients. Results The laboratory results were significantly difference between type O and non-type O COVID19 patients (P < 0.05). Patients with blood type O had lower risk of severe COVID-19 infection (χ 2 = 4.066, p = 0.044, OR = 0.380), and especially, female with the type O blood had lower risk in deteriorating severe COVID19 infection (p = 0.049). Conclusion Patients with the blood group of type O had relatively lower risk of COVID19 infection, especially, female with the type O blood had lower risk in deteriorating severe COVID19 infection. We should concern more to the patients with non-type O blood to minimize the risk of COVID19 infection.
BibTeX
@inproceedings{peng2020distribution,
  author = {Minfei Peng and Shigao Huang and Shitu Zhu and Chaochao Chen and Jiajia Qin and Minmin He and Jie Yang and Qi Zhao},
  title = {{Distribution of ABO blood groups and association to low risk of COVID-19 infection in patients}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-32315/v1},
}
Figure